ACP3 and heart failure: This conclusion is supported by the data showing that facilitated breakdown of extracellular ATP in the RVLM in conditions of a virally driven expression of a potent ATP-degrading enzyme, TMPAP, leads to a reduction in plasma level of noradrenaline and attenuates the progression of LV remodelling and heart failure secondary to MI.